Next Article in Journal
Independent and Opposite Associations Between Branched-Chain Amino Acids and Lysophosphatidylcholines With Incident Diabetes in Thais
Previous Article in Journal
Absolute Quantification of the Central Carbon Metabolome in Eight Commonly Applied Prokaryotic and Eukaryotic Model Systems
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

LAMA-1: A Cerebroside Isolated from the Deep-Sea-Derived Fungus Penicillium chrysogenum †

1
Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia
2
Department of Pharmacognosy, Faculty of Pharmacy, Suez Canal University, Ismailia 41522, Egypt
3
Department of Natural Products, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia
4
Department of Pharmacognosy, Faculty of Pharmacy, Port Said University, Port Said 42526, Egypt
*
Authors to whom correspondence should be addressed.
Dedication: Dedicated to LAMA SAMEH.
Metabolites 2020, 10(2), 75; https://doi.org/10.3390/metabo10020075
Submission received: 6 January 2020 / Revised: 10 February 2020 / Accepted: 17 February 2020 / Published: 20 February 2020

Abstract

:
Chemical investigation of the ethyl acetate extract of Penicillium chrysogenum strain S003, a fungus isolated from Red Sea deep sediment, led to the isolation of a cerebroside molecular species LAMA (1) along with three other known compounds, ergosterol (2), epidioxyergosterol (3), and kojic acid (4). The structures of the isolated compounds were elucidated by interpretation of spectral data, including detailed 1D and 2D NMR (One and two dimensional Nuclear Magnetic Resonance) and mass spectrometry. The cytotoxic activities of isolated compounds 14 against five human carcinoma cells were evaluated using sulforhodamine B (SRB) assay. Compounds 2 and 3 displayed promising cytotoxic profiles against lung cancer (A-549), prostate (DU-145), breast adenocarcinoma (MCF-7), and hepatocellular (HepG2) cell lines, with IC50 values of 21.26, 19.3; 1.50, 6.10; 16.95, 13.6; and 2.89, 3.07 µM, respectively, while they were inactive against HeLa cells. Compounds 1 and 4 showed weak cytotoxic profiles against all cell lines under investigation.

1. Introduction

Marine-derived fungi are recognized as a great source of potentially useful natural products [1,2]. Since the late 1990s, hundreds of novel compounds have been isolated and characterized from marine habitats annually [3], in stark contrast to their terrestrial counterparts. The most explored fungal isolates by the natural products chemists are the Penicillium species, which are considered a major source for drug discovery [4,5,6,7,8]. Currently, as reported in many recent reviews [9,10,11,12,13], the Penicillium genus still represents a major producer of diverse biologically active metabolites.
The Penicillium genus and its different spp. are fast-growing, salt-tolerant, and can easily be obtained and subcultured from various substrates, so the high number of reported metabolites could be justified by this fact. This has encouraged many researchers to study variable Penicillium species isolated from different habitats [6]. Their extensive investigation is concerned with the isolation, characterization, and bioactivity assessment of the obtained secondary metabolites. Among the significant reported activities are antibacterial [14,15,16,17], cytotoxic, and anticancer [16,17,18,19,20,21] activities.
In the course of our ongoing efforts to isolate and identify drug leads from marine metabolites [22,23,24,25,26,27], we have investigated the extract of the Red Sea deep-sediment isolated fungus Penicillium chrysogenum strain S003.
Here, we report the isolation, structure elucidation, and cytotoxic profiles of the purified compounds, including a cerebroside molecular species (1), together with the known reported compounds ergosterol (2) [28,29,30], epidioxyergosterol (3) [30,31], and kojic acid (4) [32,33,34,35].

2. Results and Discussion

2.1. Isolation and Purification of Compounds 14

The chromatographic fractionation of extracts from the broth and mycelia of fungus Penicillium chrysogenum strain S003 using silica gel and Sephadex LH-20 column chromatography resulted in the isolation of four separate compounds (14). Compound 1 was assigned as a cerebroside molecular species, and the name LAMA was assigned to this compound.

2.2. Structural Elucidation of Compounds 14

Compound 1 (Figure 1) was isolated as a white solid, showing a single spot on Thin-layer chromatography (TLC). Compound 1 exhibited strong hydroxy (3343 cm−1) and amide absorption (1646, 1540 cm−1) bands in the IR spectrum (Figure S1).
The 1H-NMR spectrum (Figure S2) showed characteristic signals of an amide proton doublet at δH 8.33 (1H, d, J = 8.5 Hz), long methylene chain protons at δH 1.25, overlapped methyls at δH 0.85, and signals that corresponded to a monosaccharide (an anomeric proton at δH 4.91 (1H, d, J = 7.8 Hz), indicating a glycosphingolipid nucleus. The distinguishing peaks of 2-amino-1, 3,2′-triol of the hydrocarbon chain were detected at δH 4.77 (1H, m, H-2), 5.09 (1H, dd, J = 4.9, 0.7 Hz, H-2′), 4.75 (1H, m, H-1b), 4.24 (1H, dd, J = 10.4, 3.6 Hz, H-1a), and 4.77 (1H, m, H-3), and at δC 54.7 (C-2), 73.4 (C-2′), 70.03 (C-1), and 72.2 (C-3) in the NMR spectra.
The 13C-NMR spectrum (Figure S3) also revealed characteristic carbon peaks at δC 62.6 (CH2), 71.5 (CH), 75.1 (CH), 78.4 (CH), 78.5 (CH), and 105.6 (CH), indicative of the existence of sugar moiety. The 1H- and 13C-NMR spectra in the HSQC spectrum (Table 1, Figure S4) showed a disubstituted double bond at C-4 [δH 5.99 (1H,dd, J = 15.2, 5.2 Hz, H-4), δC 131.8 (CH, C-4), δH 5.96 (1H, dt, J = 15.5, 5.5 Hz, H-5), and δC 131.1 (CH, C-5)], an additional trisubstituted double bond [δH 5.25 (1H, brst, J = 7.8 Hz, H-8), δC 124.1 (CH, C-8), and δC 135.9 (C, C-9)] in long-chain base residues, and an extra disubstituted double bond [δH 6.11 (1H, dd, J = 15.3, 5.1 Hz, H-3′), δC 130.0 (CH, C-3′), δH 6.18 (1H, dt, J = 15.3, 6.4 Hz, H-4′), and δC 132.2 (CH, C-4′)] (Table 1) in fatty acid residues. The large vicinal coupling constant of olefinic protons at C-4 (JH4–H5 = 15.5 Hz) clearly indicated an E geometry for the double bond [36], which was further supported by the chemical shift of allylic carbons [δC 33.0 (C-6)] [37]. By the same manner, the geometry of the double bond at C-3′ was presumed to be E due to the large vicinal coupling constant of the olefinic protons (JH3′–4′ = 15.3 Hz) [36]. The geometry of the double bond at C-8 was presumed to be E due to the 13C-NMR signal of the methyl group attached to C-8 at δC 16.1, while that of a (Z)-C=C bond appeared at δC 22.7 [38]. The 2-amino-1,3-dioxigenated-4-ene moiety was confirmed by COSY correlations for H-1 through H-8 (Figure 1, Figure S5). The key HMBC correlations (Table 1, Figure S6), from H-1 to C-1″; from 2-NH to C-1′; from H-2 to C-1; from H-3 to C-2; from H-5 to C-3 and C-6; from H-8 to C-9; from H-10 to C-9; from CH3 at C-9; from CH3 at C-9 to C-8 and C-9; from H-2′ to C-1′, C-3′, and C-4′; and from H-3′ to C-1′, showed the connections C1-O-C1″ and C2-NH-C1′. Both connections were indicative of 1-O-glucopyranosyl-2-amido-3,2′-dihydroxy-9-methyl-4,8-diene groups (Figure 1). Furthermore, compound 1 was proposed to have normal-type side chain [37] because the terminal methyl signals in the 13C-NMR spectrum were detected at δC 14.2 (normal type) (Table 1, Figure S3).
The negative-ion FAB-MS spectrum [M − H] showed a succession of molecular ion peaks (Figure S7) at m/z: 710, 724, 738, and 752, with characteristic fragments at m/z: 310 and 268 indicating C-16 and C-19 long-chain bases. Therefore, the previously mentioned spectral data showed that compound 1 was assumed to be a molecular species of sphingosine-type cerebrosides with 2-hydroxy fatty acid.
The configuration of compound 1 was deduced to be (2S, 3R, 2′R), since the aforementioned 13C- NMR signals (C-1, C-2, C-3, C-2′) and 1H-NMR (H-2, H-3, H-2′), in addition to optical rotation value [ α ] D 19 = −7), were fitted with sphingosine-type cerebroside molecular species possessing (2S, 3R, 2′R) conformations [39].
The sugar moiety and length of the fatty acid residues were identified via methanolysis with methanolic hydrochloric acid of compound 1 followed by partition with n-hexane. After separating the two layers, the hexane layer gave a mixture of fatty acid methyl esters (FAMEs), while the aqueous layer afforded methylated sugar moiety. HPLC comparison between the methylated sugar against standard methylated sugars (glucose and galactose) confirmed that the sugar moiety was glucose (glucose tR = 14.11 min, galactose tR = 13.27). The anomeric proton-coupling constant at δH 4.91 (1H, d, J = 7.8 Hz) and the chemical shift of the anomeric carbon δC (105.6) confirmed the β-configuration of the glucopyranoside moiety (α-glucopyranoside: J = 3.7 Hz; δC 98.5) [36]. Analysis of the negative FAB-MS spectrum of the FAME mixture exhibited the presence of four components at m/z: 269, 283, 297, and 453 [M − H], which were considered as FAME-1, FAME-2, FAME-3, and FAME-4, indicating C-16, C-17, C-18, and C-22 FAMEs, respectively (Figure S8). Compound 1 (Figure 1) was first hydrolyzed, then the reaction mixture was extracted with hexane, and the hexane layer was concentrated to afford a mixture of the methyl esters of the α-hydroxy configuration fatty acids [ α ] D 19 = −5.0 (c 0.12, CHCl3) [39,40,41,42].
The method of Tanaka et al. [43] was used for determination of the absolute configuration of sugar moiety. Direct HPLC analysis of the sugar moiety reaction mixture exhibited a peak at tR =18.68 min, which was matched with derivatives of D-glucose, confirming the absolute configuration of the sugar moiety (L-glucose tR = 19.22 min). From previous data, the structure of compound 1 was identified as molecular species cerebroside, as shown in Figure 1. The name LAMA was assigned to compound 1.
Due to the considerable importance of determining the molecular species composition of sphingolipids, isolation and structure elucidation of the cerebroside components in the molecular species of LAMA were conducted. By using reversed phase column, LAMA was fractionated to give LAMA-1. On the basis of the molecular mass of LAMA-1, m/z 748 [M + Na]+, 726 [M + H]+, 724 [M − H], and the characteristic fragments at m/z 562 corresponding to the aglycone part in addition to m/z 472 corresponding to glucosylated long chain base (Figures S7 and S9), the structure of this compound was considered resolved, as shown in Figure 2.
In addition to LAMA-1, the structures of other known compounds 24 (Figure 1) were elucidated by comparing their detailed NMR spectral data with those in the literature. These compounds were identified as ergosterol (2) [28,29,30], epidioxyergosterol (3), [30,31], and kojic acid (4) [32,33,34,35].

2.3. Cytotoxic Activity of Isolated Compounds 14

The isolated compounds 14 were evaluated for their cytotoxic activity against five selected human cancer cell lines (Table 2) using SRB assay. Compounds 2 and 3 displayed a promising cytotoxic profile against lung-cancer (A-549), prostate cancer (DU-145), breast adenocarcinoma (MCF-7), and hepatocellular carcinoma (HepG2) cell lines with IC50 values of 21.26, 19.3; 1.50, 6.10; 16.95, 13.6; and 2.89, 3.07 µM, respectively, while they were inactive against HeLa cells. Compounds 1 and 4 showed weak cytotoxic profiles against all cell lines under investigation (Table 2).

3. Materials and Methods

3.1. Biological Materials

The fungus Penicillium chrysogenum strain S003 (Figure 3) was cultured from deep-sea sediment from the Red Sea, and the fungal strain was identified based on a previously described method [26].

3.2. Fermentation and Extraction of Fungus Penicillium chrysogenum Strain S003

Fungus Penicillium chrysogenum strain S003 was cultured at 25 ℃ in 2 L Erlenmeyer flasks containing 500 mL of Czapek–Dox yeast liquid culture medium, composed of (NaNO3 3.0 g/L, KCl 0.5 g/L, K2HPO4 0.1 g/L, MgSO4·7H2O 0.5 g/L, FeSO4 0.01 g/L, sucrose 30.0 g/L, yeast extract 5.0 g/L and NaCl 20.0 g/L). After cultivation for 30 days under static conditions, 15 L of the whole broth was filtrated using cheesecloth. Extraction of the broth with ethyl acetate was performed three times, and was further dried under vacuum to afford an ethyl acetate extract (1.4 g), while the mycelia were extracted three times with MeOH. The MeOH solution was partitioned with n-hexane, followed by evaporation to give a MeOH extract and an n-hexane extract (5 g). The MeOH extract was dissolved in water and partitioned with CHCl3, followed by evaporation under reduced pressure to produce an CHCl3 extract (2.8 g). The resulting extracts were subjected to further fractionation and separation to obtain the pure compounds.

3.3. Isolation and Purification of Compounds 14

The resulting CHCl3 extract (C-M-C, 2.8 g) from the previous section was chromatographed using CHCl3: MeOH (9.5:0.5~4:6) on SiO2 gel to yield 11 subfractions (C-M-C-1 to C-M-C-11). Fraction C-M-C-7 (325 mg) was subjected to a Sephadex LH-20 column and eluted with MeOH to afford 5 fractions (C-M-C-7-1 to C-M-C-7-5). Fraction C-M-C-7-1 (194 mg) was passed through a SiO2 gel column using CHCl3/MeOH (97:3 to 90:10) to afford two subfractions (C-M-C-7-1-1 to C-M-C-7-1-2). Fraction C-M-C-7-1-2 (80 mg) was chromatographed over a SiO2 gel column using CHCl3/MeOH (95:5) to yield phytoceramide molecular species compound (1) (30 mg). The name LAMA was assigned to compound 1. Compound 1 was fractionated over reversed-phase column chromatography using H2O/MeOH (2:8 to 0.5:9.5) to give LAMA-1.
The EtOAc extract (C-E, 1.4 g) was eluted on Sephadex LH-20 column with MeOH/CHCl3 (1:1) to yield 10 subfractions (C-E-1 to C-E-10). Fraction C-E-4 (0.5 g) was passed through a SiO2 column with increasing EtOAc in n-hexane as eluent to obtain six fractions (C-E-4-1 to C-E-4-6). Fraction C-E-4-3 (195 mg) was subject to further chromatography using n-hexane: EtOAc (9.5:0.5 to 1:9) over a SiO2 gel column to give eight fractions (C-E-4-3-1 to C-E-4-3-8). Fraction C-E-4-3-2 (24 mg) was purified over a silica gel column using n-hexane/EtOAc (9.5:0.5 to 1:1) to get ergosterol (2) (3.1 mg) and epidioxyergosterol (3) (1.4 mg).
Chromatography for fraction C-E-6 (190 mg) over the SiO2 gel column using n-hexane/EtOAc (2:8 to 0:10) gradient elution produced seven subfractions (C-E-6-1 to C-E-6-7). Fraction C-E-6-4 (57 mg) was fractionated using MeOH/H2O (6:4) isocratic elution on reversed phase column, followed by gradient elution using n-hexane/EtOAc (2:8~0:10) on SiO2 gel column to obtain kojic acid (4) (20 mg).

3.4. Cytotoxicity of Compounds 14

The cytotoxic activity (Table 2) of the compounds on lung cancer A-549, cervical cancer HeLa, prostate cancer DU-145, hepatocellular carcinoma HepG2, and breast-adenocarcinoma MCF-7 cells was determined using an SRB assay [44,45], as mentioned in our study [46].

4. Conclusions

Chemical investigation of deep-sediment-derived Penicillium chrysogenum S003 yielded a cerebroside molecular species (1), and three known compounds: ergosterol (2), epidioxyergosterol (3), and kojic acid (4). The chemical structures of purified compounds 14 were characterized using spectroscopic studies and by comparison with available data in the literature. The cytotoxic activities of isolated compounds 14 against five human carcinoma cells were evaluated using an SRB assay. Compounds 2 and 3 displayed a promising cytotoxic profiles against lung cancer (A-549), prostate cancer (DU-145), breast adenocarcinoma (MCF-7), and hepatocellular carcinoma (HepG2) cell lines with IC50 values of 21.26, 19.3; 1.50, 6.10; 16.95, 13.6; and 2.89, 3.07 µM, respectively, while they were inactive against HeLa cells. Compounds 1 and 4 showed weak cytotoxic profiles against all cell lines under investigation.

Supplementary Materials

The supplementary materials are available online at https://www.mdpi.com/2218-1989/10/2/75/s1. Figure S1. IR spectrum of compound LAMA; Figure S2. 1H-NMR spectrum of compound LAMA (pyridine-d5); Figure S3. 13C-NMR spectrum of compound LAMA (pyridine-d5); Figure S4. HSQC spectrum of compound LAMA (pyridine-d5); Figure S5. 1H-1H COSY spectrum of compound LAMA (pyridine-d5); Figure S6. HMBC spectrum of compound LAMA (pyridine-d5); Figure S7. FABMS spectrum of compound LAMA; Figure S8. FAM-FABMS spectrum of compound LAMA; Figure S9. FABMS spectrum of compound LAMA-1.

Author Contributions

Conceptualization, R.F.A.A and S.S.E.; marine sediment collection, S.S.E.; experiment design, R.F.A.A. and S.S.E.; methodology, R.F.A.A. and S.S.E.; software, S.S.E. and S.O.A.; resources, S.S.E., A.K.I., and H.A.B.; data curation, S.S.E. and H.A.B.; funding acquisition, A.O.N., S.O.A., and R.T.M.; writing—original draft preparation, S.S.E, A.K.I., and R.F.A.A.; writing—review and editing, S.O.A. and S.S.E. All authors have read and agreed to the published version of the manuscript.

Funding

This project was funded by the Deanship of Scientific Research (DSR) at King Abdulaziz University, Jeddah, under Grant No. G-464-249-1439. The authors, therefore, acknowledge with thanks DSR for technical and financial support.

Conflicts of Interest

All contributing authors declare no conflicts of interest to disclose, whether financial or of any other nature.

References

  1. Bugni, T.S.; Ireland, C.M. Marine-derived fungi: a chemically and biologically diverse group of microorganisms. Nat. Prod. Rep. 2004, 21, 143–163. [Google Scholar] [CrossRef] [PubMed]
  2. Fenical, W. Chemical studies of marine bacteria: developing a new resource. Chem. Rev. 1993, 93, 1673–1683. [Google Scholar] [CrossRef]
  3. Blunt, J.W.; Copp, B.R.; Keyzers, R.A.; Munro, M.H.G.; Prinsep, M.R. Marine natural products. Nat. Prod. Rep. 2013, 30, 237–323. [Google Scholar] [CrossRef] [PubMed]
  4. Youssef, D.T.; Alahdal, A.M. Cytotoxic and Antimicrobial Compounds from the Marine-Derived Fungus, Penicillium Species. Molecules 2018, 23, 394. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Shaala, L.A.; Youssef, D.T. Identification and bioactivity of compounds from the fungus Penicillium sp. CYE-87 isolated from a marine tunicate. Mar. Drugs 2015, 13, 1698–1709. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Murshid, S.S.; Badr, J.M.; Youssef, D.T. Penicillosides A and B: New cerebrosides from the marine-derived fungus Penicillium species. Rev. Bras. Farmacogn. 2016, 26, 29–33. [Google Scholar] [CrossRef] [Green Version]
  7. Mourshid, S.S.; Badr, J.M.; Risinger, A.L.; Mooberry, S.L.; Youssef, D.T. Penicilloitins A and B, new antimicrobial fatty acid esters from a marine endophytic Penicillium species. Z. Naturforsch. C 2016, 71, 387–392. [Google Scholar] [CrossRef]
  8. Asiri, I.A.; Badr, J.M.; Youssef, D.T. Penicillivinacine, antimigratory diketopiperazine alkaloid from the marine-derived fungus Penicillium vinaceum. Phytochem. Lett. 2015, 13, 53–58. [Google Scholar] [CrossRef]
  9. Rateb, M.E.; Ebel, R. Secondary metabolites of fungi from marine habitats. Nat. Prod. Rep. 2011, 28, 290–344. [Google Scholar] [CrossRef]
  10. Blunt, J.W.; Copp, B.R.; Keyzers, R.A.; Munro, M.H.G.; Prinsep, M.R. Marine natural products. Nat. Prod. Rep. 2017, 34, 235–294. [Google Scholar] [CrossRef] [Green Version]
  11. Wang, Y.T.; Xue, Y.R.; Liu, C.H. A Brief Review of Bioactive Metabolites Derived from Deep-Sea Fungi. Mar. Drugs 2015, 13, 4594–4616. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Imhoff, J.F. Natural products from marine fungi—Still an underrepresented resource. Mar. Drugs 2016, 14, 19. [Google Scholar] [CrossRef] [PubMed]
  13. Nicoletti, R.; Trincone, A. Bioactive Compounds Produced by Strains of Penicillium and Talaromyces of Marine Origin. Mar. Drugs 2016, 14, 37. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Qi, S.-H.; Xu, Y.; Xiong, H.-R.; Qian, P.-Y.; Zhang, S. Antifouling and antibacterial compounds from a marine fungus Cladosporium sp. F14. World J. Microbiol. Biotechnol. 2009, 25, 399. [Google Scholar] [CrossRef]
  15. Devi, P.; Rodrigues, C.; Naik, C.; D’souza, L. Isolation and characterization of antibacterial compound from a mangrove-endophytic fungus, Penicillium chrysogenum MTCC 5108. Indian J. Microbiol. 2012, 52, 617–623. [Google Scholar] [CrossRef] [Green Version]
  16. Abo-Kadoum, M.; Abo-Dahab, N.; Awad, M.; Abdel-Hadi, A. Marine-derived fungus, Penicillium aurantiogriseum AUMC 9757: A producer of bioactive secondary metabolites. J. Basic Appl. Mycol. 2013, 4, 77–83. [Google Scholar]
  17. Subramani, R.; Kumar, R.; Prasad, P.; Aalbersberg, W. Cytotoxic and antibacterial substances against multi-drug resistant pathogens from marine sponge symbiont: Citrinin, a secondary metabolite of Penicillium sp. Asian Pac. Trop. Biomed. 2013, 3, 291–296. [Google Scholar] [CrossRef] [Green Version]
  18. Wang, Y.-N.; Tian, L.; Hua, H.-M.; Lu, X.; Sun, S.; Wu, H.-H.; Pei, Y.-H. Two new compounds from the broth of the marine fungus Penicillium griseofulvum Y19-07. J. Asian Nat. Prod. Res. 2009, 11, 912–917. [Google Scholar] [CrossRef]
  19. Wang, W.; Wang, Y.; Tao, H.; Peng, X.; Liu, P.; Zhu, W. Cerebrosides of the halotolerant fungus Alternaria raphani isolated from a sea salt field. J. Nat. Prod. 2009, 72, 1695–1698. [Google Scholar] [CrossRef]
  20. Sun, Y.; Takada, K.; Takemoto, Y.; Yoshida, M.; Nogi, Y.; Okada, S.; Matsunaga, S. Gliotoxin Analogues from a Marine-Derived Fungus, Penicillium sp., and Their Cytotoxic and Histone Methyltransferase Inhibitory Activities. J. Nat. Prod. 2012, 75, 111–114. [Google Scholar] [CrossRef]
  21. Gao, H.; Zhou, L.; Li, D.; Gu, Q.; Zhu, T.J. New Cytotoxic Metabolites from the Marine-Derived Fungus Penicillium sp. ZLN29. Helv. Chim. Acta 2013, 96, 514–519. [Google Scholar] [CrossRef]
  22. Elhady, S.S.; El-Halawany, A.M.; Alahdal, A.M.; Hassanean, H.A.; Ahmed, S.A. A New Bioactive Metabolite Isolated from the Red Sea Marine Sponge Hyrtios erectus. Molecules 2016, 21, 82. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Elhady, S.S.; Al-Abd, A.M.; El-Halawany, A.M.; Alahdal, A.M.; Hassanean, H.A.; Ahmed, S.A. Antiproliferative Scalarane-Based Metabolites from the Red Sea Sponge Hyrtios erectus. Mar. Drugs 2016, 14, 130. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Alahdal, A.M.; Shaala, L.A.; Noor, A.O.; Elfaky, M.A.; Elhady, S.S.; Almohammadi, A.; Bagalagel, A.; Lashkar, M.O.; Almasri, D.M.; Youssef, D. Evaluation of the antiproliferative and cytotoxic activities of marine invertebrates-derived fungi. Pak. J. Pharm. Sci. 2017, 30, 1001–1006. [Google Scholar]
  25. Bagalagel, A.A.; Bogari, H.A.; Ahmed, S.A.; Diri, R.M.; Elhady, S.S. New Bromoindole Alkaloid Isolated from the Marine Sponge Hyrtios erectus. Heterocycles 2018, 96, 749–756. [Google Scholar]
  26. Asfour, H.Z.; Awan, Z.A.; Bagalagel, A.A.; Elfaky, M.A.; Abdelhameed, R.F.A.; Elhady, S.S. Large-Scale Production of Bioactive Terrein by Aspergillus terreus Strain S020 Isolated from the Saudi Coast of the Red Sea. Biomolecules 2019, 9, 480. [Google Scholar] [CrossRef] [Green Version]
  27. Abdelhameed, R.F.; Elhady, S.S.; Noor, A.O.; Almasri, D.M.; Bagalagel, A.A.; Maatooq, G.T.; Khedr, A.I.; Yamada, K. Production of a New Cyclic Depsipeptide by the Culture Broth of Staphylococcus sp. Isolated from Corallina officinalis L. Metabolites 2019, 9, 273. [Google Scholar] [CrossRef] [Green Version]
  28. Adler, J.H.; Young, M.; Nes, W.R. Determination of the absolute configuration at C-20 and C-24 of ergosterol in ascomycetes and basidiomycetes by proton magnetic resonance spectroscopy. Lipids 1977, 12, 364–366. [Google Scholar] [CrossRef]
  29. Smith, W.B. The carbon-13 spectra of steroids on the way to ecdysone. Magn. Reson. Chem. 1977, 9, 644–648. [Google Scholar] [CrossRef]
  30. Shang, Z.; Li, X.; Meng, L.; Li, C.; Gao, S.; Huang, C.; Wang, B. Chemical profile of the secondary metabolites produced by a deep-sea sediment-derived fungus Penicillium commune SD-118. Chin. J. Oceanol. Limnol. 2012, 30, 305–314. [Google Scholar] [CrossRef]
  31. Yue, J.-M.; Chen, S.-N.; Lin, Z.-W.; Sun, H.-D. Sterols from the fungus Lactarium volemus. Phytochemistry 2001, 56, 801–806. [Google Scholar] [CrossRef]
  32. Saito, K. Über die Säurebildung bei Aspergillus Oryzae. Bot. Mag. 1907, 21, 7–11. [Google Scholar] [CrossRef] [Green Version]
  33. Li, X.; Jeong, J.H.; Lee, K.T.; Rho, J.R.; Choi, H.D.; Kang, J.S.; Son, B.W. γ-Pyrone derivatives, kojic acid methyl ethers from a marine-derived fungus altenaria sp. Arch. Pharmacal Res. 2003, 26, 532–534. [Google Scholar] [CrossRef] [PubMed]
  34. Terabayashi, Y.; Sano, M.; Yamane, N.; Marui, J.; Tamano, K.; Sagara, J.; Dohmoto, M.; Oda, K.; Ohshima, E.; Tachibana, K.; et al. Identification and characterization of genes responsible for biosynthesis of kojic acid, an industrially important compound from Aspergillus oryzae. Fungal Genet. Biol. 2010, 47, 953–961. [Google Scholar] [CrossRef] [PubMed]
  35. Li, Y.; Teng, Z.; Parkin, K.L.; Wang, Q.; Zhang, Q.; Luo, W.; Ma, D.; Zhao, M. Identification of bioactive metabolites dihydrocanadensolide, kojic acid, and vanillic acid in soy sauce using GC-MS, NMR spectroscopy, and single-crystal X-ray diffraction. J. Agric. Food Chem. 2014, 62, 8392–8401. [Google Scholar] [CrossRef] [PubMed]
  36. Yang, G.; Sandjo, L.; Yun, K.; Leutou, A.S.; Kim, G.-D.; Choi, H.D.; Kang, J.S.; Hong, J.; Son, B.W. Flavusides A and B, antibacterial cerebrosides from the marine-derived fungus Aspergillus flavus. Chem. Pharm. Bull. 2011, 59, 1174–1177. [Google Scholar] [CrossRef] [Green Version]
  37. Yoder, B.J.; Cao, S.; Norris, A.; Miller, J.S.; Ratovoson, F.; Andriantsiferana, R.; Rasamison, V.E.; Kingston, D.G. Tambouranolide, a new cytotoxic hydroxybutanolide from a Tambourissa sp. (Monimiaceae). Nat. Prod. Res. 2007, 21, 37–41. [Google Scholar] [CrossRef]
  38. Li, Y.Y.; Liu, P.; Tang, Y.; Li, H.M.; Tang, Y.L.; Liang, X.H.; Tang, Y.J. Novel cerebrosides isolated from the fermentation mycelia of Tuber indicum. Helv. Chim. Acta 2013, 96, 702–709. [Google Scholar] [CrossRef]
  39. Chiu, C.-P.; Liu, S.-C.; Tang, C.-H.; Chan, Y.; El-Shazly, M.; Lee, C.-L.; Du, Y.-C.; Wu, T.-Y.; Chang, F.-R.; Wu, Y.-C. Anti-inflammatory cerebrosides from cultivated Cordyceps militaris. J. Agric. Food Chem. 2016, 64, 1540–1548. [Google Scholar] [CrossRef]
  40. Jin, W.; Rinehart, K.L.; Jares-Erijman, E.A. Ophidiacerebrosides: cytotoxic glycosphingolipids containing a novel sphingosine from a sea star. J. Org. Chem. 1994, 59, 144–147. [Google Scholar] [CrossRef]
  41. Hitchcock, C.; Morris, L.; James, A. The Stereochemistry of α-Oxidation of Fatty Acids in Plants: The Configuration of Biosynthetic Long-Chain 2-Hydroxyacids. Eur. J. Biochem. 1968, 3, 473–475. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  42. Sitrin, R.D.; Chan, G.; Dingerdissen, J.; Debrosse, C.; Mehta, R.; Roberts, G.; Rottschaefer, S.; Staiger, D.; Valenta, J.; Snader, K.M.; et al. Isolation and structure determination of Pachybasium cerebrosides which potentiate the antifungal activity of aculeacin. J. Antibiot. 1988, 41, 469–480. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Tanaka, T.; Nakashima, T.; Ueda, T.; Tomii, K.; Kouno, I. Facile discrimination of aldose enantiomers by reversed-phase HPLC. Chem. Pharm. Bull. 2007, 55, 899–901. [Google Scholar] [CrossRef] [Green Version]
  44. Skehan, P.; Storeng, R.; Scudiero, D.; Monks, A.; McMahon, J.; Vistica, D.; Warren, J.T.; Bokesch, H.; Kenney, S.; Boyd, M.R. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst. 1990, 82, 1107–1112. [Google Scholar] [CrossRef] [PubMed]
  45. Mahmoud, A.M.; Al-Abd, A.M.; Lightfoot, D.A.; El-Shemy, H.A. Anti-cancer characteristics of mevinolin against three different solid tumor cell lines was not solely p53-dependent. J. Enzyme Inhib. Med. Chem. 2012, 27, 673–679. [Google Scholar] [CrossRef]
  46. Alahdal, A.; Asfour, H.; Ahmed, S.; Noor, A.; Al-Abd, A.; Elfaky, M.; Elhady, S. Anti-helicobacter, antitubercular and cytotoxic activities of scalaranes from the red sea sponge Hyrtios erectus. Molecules 2018, 23, 978. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Figure 1. Structures of isolated compounds 14.
Figure 1. Structures of isolated compounds 14.
Metabolites 10 00075 g001
Figure 2. Structure of compound LAMA-1.
Figure 2. Structure of compound LAMA-1.
Metabolites 10 00075 g002
Figure 3. Morphological photo of the deep-sea-sediment-derived Penicillium chrysogenum strain S003.
Figure 3. Morphological photo of the deep-sea-sediment-derived Penicillium chrysogenum strain S003.
Metabolites 10 00075 g003
Table 1. NMR (Nuclear Magnetic Resonance) data of 1 (pyridine-d5).
Table 1. NMR (Nuclear Magnetic Resonance) data of 1 (pyridine-d5).
PositionδCδH (m, J in Hz)HMBC (H→C) a
170.0, CH24.24 (dd, 10.4, 3.6)
4.75 (m)
C-1″
254.7, CH4.77 (m)C-1
372.2, CH4.77 (m)C-2
4131.8, CH5.99 (dd, 15.5, 5.2)C-3, C-6
5132.2, CH5.96 (m), (dd, 15.5,5.5)C-3, C-6
633.0, CH22.14 (m)
732.1, CH22.14 (m)
8124.1, CH5.25 (br t 7.8)C-9
9135.9, CH
1040.0, CH22.00 (t, 7.7)C-9, C-9CH3
1′173.8, C
2′73.4, CH5.09 (dd, 4.9, 0.76)C-1′, C-3′, C-4′
3′130.0, CH6.11 (dd, 15.3, 5.1)C-1′
4′132.2, CH6.18 (dt, 15.3, 6.4)
1″105.6, CH4.91 (d, 7.8 )
2″75.1, CH4.02 (t, 6.6 )
3″78.4, CH4.22 (m)
4″71.5, CH4.22 (m)
5″78.5, CH3.90 (m)
6″62.6, CH24.35 (dd, 11.8, 5.4)
4.51 (dd, 11.9, 2.5)
CH314.2, CH30.85 (t, 7)
9CH316.1, CH31.61 (s)C-8, C-9
NH 8.33 (d, 8.5)C-1′
a HMBC correlations are from proton(s) stated to the indicated carbons.
Table 2. Cytotoxic activities of compounds 14 in µM against five selected human solid tumor cell lines (n = 3).
Table 2. Cytotoxic activities of compounds 14 in µM against five selected human solid tumor cell lines (n = 3).
Cell TypeCell Line1234
Lung cancerA-549>10021.26 ± 0.18 19.30 ± 0.27>100
Cervical cancerHeLa>100>100>100>100
Prostate cancerDU-145>1001.5 ± 0.036.1 ± 0.18>100
Hepatocellular carcinomaHepG2>1002.89 ± 0.233.07 ± 0.97>100
Breast adenocarcinoma MCF-7>10016.95 ± 0.5313.6 ± 0.38>100

Share and Cite

MDPI and ACS Style

Alshehri, S.O.; Malatani, R.T.; Bogari, H.A.; Noor, A.O.; Ibrahim, A.K.; Elhady, S.S.; Abdelhameed, R.F.A. LAMA-1: A Cerebroside Isolated from the Deep-Sea-Derived Fungus Penicillium chrysogenum. Metabolites 2020, 10, 75. https://doi.org/10.3390/metabo10020075

AMA Style

Alshehri SO, Malatani RT, Bogari HA, Noor AO, Ibrahim AK, Elhady SS, Abdelhameed RFA. LAMA-1: A Cerebroside Isolated from the Deep-Sea-Derived Fungus Penicillium chrysogenum. Metabolites. 2020; 10(2):75. https://doi.org/10.3390/metabo10020075

Chicago/Turabian Style

Alshehri, Samah O., Rania T. Malatani, Hanin A. Bogari, Ahmad O. Noor, Amany K. Ibrahim, Sameh S. Elhady, and Reda F. A. Abdelhameed. 2020. "LAMA-1: A Cerebroside Isolated from the Deep-Sea-Derived Fungus Penicillium chrysogenum" Metabolites 10, no. 2: 75. https://doi.org/10.3390/metabo10020075

APA Style

Alshehri, S. O., Malatani, R. T., Bogari, H. A., Noor, A. O., Ibrahim, A. K., Elhady, S. S., & Abdelhameed, R. F. A. (2020). LAMA-1: A Cerebroside Isolated from the Deep-Sea-Derived Fungus Penicillium chrysogenum. Metabolites, 10(2), 75. https://doi.org/10.3390/metabo10020075

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop